Medicus Pharma Ltd.
MDCX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001997296
No open-market purchases or sales by Medicus Pharma Ltd. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $1.18M in total; no superinvestor holds it.
Other share classesMDCXW
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Medicus Pharma Ltd. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Medicus Pharma Ltd., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Smith Andrew Alasdair | Chief Operating Officer | 735,458 | Sep 8, 2026 | 4 |
| Mehmud Faisal | Chief Medical Officer | 1,470,588 | Sep 8, 2026 | 4 |
| Brennan Edward J. | Chief Scientific Officer | 674,735 | Sep 8, 2026 | 4 |
| Bonner Carolyn F. | President and CFO | 1,489,493 | Sep 8, 2026 | 4 |
| Bokhari Raza | Chief Executive Officer | 2,941,176 | Sep 8, 2026 | 4 |
| Mahaffy Patrick J | Director | – | Jun 4, 2026 | 3 |
| Ashton William | Director | – | Jun 4, 2026 | 3 |
| Fishman Barry | Director | – | Jun 4, 2026 | 3 |
| Ciaruffoli Robert J. | Director | – | Jun 4, 2026 | 3 |
| Kaiser Larry | Director | – | Jun 4, 2026 | 3 |
| May Sara R. | Director | – | Jun 4, 2026 | 3 |
| Raju Ajay | Director | – | Jun 4, 2026 | 3 |
| Rodgers Cathy McMorris | Director | – | Jun 4, 2026 | 3 |
| Quinlan James P. | Chief Financial Officer | 274,147 | Aug 14, 2025 | 0 |
| Velocity Fund Partners, LP | 10% Owner | 3,248,741Indirect | May 21, 2025 | 0 |
| Melani Kenneth R. | 10% Owner | 3,248,741Indirect | May 21, 2025 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 21, 2025 (view filing)12:57 PM ET | May 20 | 1 day | Velocity Fund Partners, LP and 1 other10% Owner | SSaleMedicus Pharma LTD | −75.0K | $7.72 | −$578.9K | −2.3%3.25M after |